Promising cell therapies are being developed that may treat major chronic and debilitating diseases impacting millions of Americans including
The best time to bank your cells is today—cellular health declines with time.
As we age and are exposed to environmental factors, the quality of our cells decreases. The healthiest cells are the ones you have right now. While therapies using donor cells may be an option, using your own eliminates the risk of rejection or the need to test for a match. Your investment today could be your body’s personalized medicine tomorrow.
It starts with a simple blood draw.
Your blood contains many cell types, including stem cells, that can potentially be used in therapies that will be available in the near future. GoodCell isolates the nucleated cells from your blood that have future therapeutic potential and stores them in a secure facility—the same one trusted by the National Institutes of Health.
GoodCell’s founders and Advisors are recognized pioneers in science and medicine.
Here’s what the visionaries are saying about GoodCell
All of our cells become specialized cells. This is particularly evident in the blood where stem cell therapies can fully restore all blood and immune cells. We now have the tools to take some of those cells, rewind their history to an earlier, stem cell stage, then guide them forward on an updated trajectory that meets a patient need."
David Scadden,Co-Founder, Harvard Stem Cell Insitute 
GoodCell Founders knew that there were all these cell and gene therapy trials happening and wanted to be able to put people in a position to benefit from these breakthroughs in the future when they would need it most. There are 23 FDA approved cellular and gene therapy products that exist today and with thousands of cell and gene therapies in development, the list will continue to grow."
Salvatore Viscomi, MD, Chief Medical Officer 
The focus of my work is the digitization of healthcare and how we harness the information age for the benefit of all people. We’re living in a very exciting time where GoodCell is putting the power of that data in patients’ hands and allowing them to access not only their own health information, but also their stored cells for future treatments should they need them. This is clearly the next step in the patient advocacy movement."
Jennifer Joe, Founder of Medtech Boston, CEO of Vanguard Health 
Ready to get started?
Your investment today could be your body’s most potent medicine tomorrow.
Have more questions? Check out our FAQ
or get in touch.
